Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL3942263

CCOc1ccccc1C#N.Cl[Pt]Cl.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPK1 P28482 1/20 0.46
AR P10275 1/20 0.45
ALDH1A1 P00352 6/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
GAA P10253 3/20 0.44
POLB P06746 1/20 0.44
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
MAOA P21397 1/20 0.43
HTR2B P41595 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451 0.91 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2MAPK1AR
SCHEMBL30283197 0.91 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2MAPK1AR
Hydrochloric Acid SCHEMBL27764098 0.89 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPK1AR
Ammonia Solution, Strong SCHEMBL3942484 0.80 POLB (0.56) NPC1RAB9ASMN1; SMN2ARALDH1A1
SCHEMBL1132618 0.77 PIP4K2A (0.48) ARALDH1A1GAAPOLBNPSR1
SCHEMBL20607680 0.77 NPC1 (0.47) NPC1RAB9ASMN1; SMN2MAPK1AR
SCHEMBL973234 0.77 ALDH1A1 (0.54) NPC1RAB9ASMN1; SMN2MAPK1ALDH1A1
SCHEMBL10499090 0.76 ALDH1A1 (0.53) NPC1RAB9ASMN1; SMN2MAPK1ALDH1A1
Acetoacetic Acid SCHEMBL27513054 0.75 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2MAPK1ALDH1A1
Hydrochloric Acid SCHEMBL13857771 0.75 ALDH1A1 (0.53) NPC1RAB9ASMN1; SMN2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569606-B2 Platinum complexes with mononitrile-containing ligands BIONUMERIK PHARMACEUTICALS, INC. (US) 2009-08-04 US disclosed
US-20070173485-A1 Amminecyclohexanecarbonitriledichloroplatinum; platinum is capable of rapidly undergoing chelation with the Guanine or Adenine base of a DNA oligonucleotide at the 7 position; readily taken up by tumor cells JUNIPER NETWORKS, INC. 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173485-A1 Amminecyclohexanecarbonitriledichloroplatinum; platinum is capable of rapidly undergoing chelation with the Guanine or Adenine base of a DNA oligonucleotide at the 7 position; readily taken up by tumor cells RNMT, NSUN2, NUDT1 NPC1 3447/4885RAB9A 2814/4885SMN1; SMN2 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.